Predictors of Medical Intractability in Children with Epilepsy Onset During the First Two Years of Life, Excluding Infantile Epileptic Spasm Syndrome

PurposeEarly childhood epilepsy presents a significant challenge, with approximately 30% of individuals experiencing treatment failure. This study aimed to identify predictors of medical intractability in children with epilepsy onset during the first two years of life, excluding infantile epileptic spasm syndrome.MethodsA total of 323 children were retrospectively evaluated. The analyses included a review of medical records for demographic, laboratory, radiological, and electroencephalographic (EEG) findings. Children were diagnosed with drug-resistant epilepsy (DRE) according to the ILAE diagnostic criteria. Twenty-one potential prognostic predictors were examined in relation to medical intractability.ResultsAmong the 323 children (56.7% male), 119 (36.8%) had unknown epilepsy, 131 (40.6%) had structural epilepsy, 53 (16.4%) had genetic epilepsy, and 20 (6.2%) had metabolic epilepsy. Over a median follow-up of 68 months, 55.4% of the children achieved ≥6 months of seizure freedom, 33.1% developed DRE, and the remaining 11.5% had rare ongoing seizures but did not meet the criteria for DRE because they were only treated with one antiseizure medication at the last follow-up. Univariate logistic regression analyses identified ten risk factors significantly associated with DRE. Multivariate logistic regression analyses revealed that the presence of developmental delay at epilepsy onset (p=0.000; OR 7.890; 95%CI 2.713 to 22.945), history of status epilepticus (p=0.000; OR 8.247; 95%CI 3.619 to 18.793), number of antiseizure medications (ASMs) at the sixth month of diagnosis (p=0.000; OR 20.585; 95%CI 8.993 to 47.117), and initial EEG findings (p=0.046; OR 2.366; 95%CI 1.015 to 5.518) were predictors of medical intractability. Nineteen (5.9%) children died during follow-up for various reasons, including progressive neurogenetic or neurodegenerative disorders.ConclusionDevelopmental delay at epilepsy onset, a history of status epilepticus, the use of two or more ASMs in the sixth month of diagnosis, and abnormal initial EEG findings were associated with medical intractability.